pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
pharmadog news

Browse

3,092 stories matching this filter · ← front page

★ save view↓export CSV
rangeto
sort
recentoldestsourcealpha
source
STAT1884Endpoints1461Fierce Biotech774BioSpace762BioPharma Dive552raps253onclive165fda recalls
therapy area
allOncology12986Rare Disease3371Immunology3063Cardiology2865Hematology2315Pulmonology2261Vaccines
  • FDA leadership search continues as lung cancer drug faces rejection and China’s top drugmakers are ranked
    The Readout LOUD podcast this week highlighted three main topics: the FDA’s ongoing search for a new commissioner, a setback for a closely watched lung cancer therapy, and a ranking of China’s bigg…
    STAT · 4h agoRegulatoryNeutral↗ source
  • Big pharma say they will stop opening new trial sites in Xinjiang and Chinese military hospitals
    Several of the world’s largest pharmaceutical companies told a U.S. House Select Committee on China that they will not start new clinical trial sites in the Xinjiang region of China or at hospitals…
    STAT · 13h agoRegulatoryNegative↗ source
← prev
page 1 of 124
next →
122
fda medwatch116
globenewswire health73
fda press62
1881
Psychiatry & CNS1237
Ophthalmology1140
Endocrinology & Metabolism809
Pain801
Nephrology788
  • UnitedHealth sues CMS over lowered 2027 Medicare Advantage star ratings
    UnitedHealth Group has filed a lawsuit against the Centers for Medicare & Medicaid Services seeking to overturn the agency’s lowered star ratings for its Medicare Advantage plans for 2027. The sui…
    STAT · 6h agoRegulatoryNegative↗ source
  • Exercise should be prescribed alongside rest for concussion recovery, author argues
    The author recounts a severe brain injury that left him in a coma, caused significant muscle loss and left-side weakness, and made simple tasks like getting out of a bathtub a struggle. He began a…
    STAT · 4h agoPositive↗ source
  • Patient coalition urges more agency for participants in brain-implant trials
    A new report released by the BCI Pioneers Coalition outlines 13 recommendations aimed at improving how brain‑computer interface trials are conducted. The guidance targets startups, researchers and…
    STAT · 4h agoNeutral↗ source
  • Only 10% of surgeons in East and Central Africa are women, highlighting gender gap in global surgery
    An opinion piece notes that women comprise just one‑tenth of the surgical workforce across twelve COSECSA member countries, a proportion that has not changed in years. The author observed a documen…
    STAT · 4h agoNegative↗ source
  • This week in charts: Biotech investors’ China bets are already paying off
    This year, companies built around medicines from China have sped toward acquisitions or IPOs. Meanwhile, Summit is no longer the Wall Street darling it was in 2024.
    BioPharma Dive · 1h ago↗ source
  • US panel warns China’s biotech plan could dominate sector and threaten drug supply chain
    A congressional commission has warned that China’s new five-year biotech plan could allow it to dominate the global drug market. The commission says the strategy could leave U.S. patients vulnerab…
    BioPharma Dive · 20h agoRegulatoryNegative↗ source
  • FDA approves Regeneron's Livsayis, first RNAi therapy for generalized myasthenia gravis
    The Food and Drug Administration approved Regeneron's Livsayis, an RNA interference drug for generalized myasthenia gravis, marking the company's first marketed RNAi therapy. The drug, originally…
    BioPharma Dive · 22h agoApprovalPositive↗ source
  • FDA approves treatments for four rare diseases; Pfizer inks $2.6 billion China licensing deal for CAR‑T therapy
    The U.S. Food and Drug Administration has granted approval for drugs targeting four distinct rare diseases, expanding therapeutic options for patients with limited treatment choices. In a separate…
    raps · 1d agoApprovalPositive↗ source
  • Merck partners with Isomorphic Labs to use AI for discovering oncology drug candidates
    Merck announced a research collaboration with Isomorphic Labs, an artificial‑intelligence drug design firm, to explore small‑molecule candidates aimed at an undisclosed oncology target. Isomorphic…
    STAT · 23h agoDealPositive↗ source
  • Merck teams with Isomorphic Labs to discover new oncology small-molecule candidates
    Merck and Isomorphic Labs announced a research collaboration aimed at discovering small-molecule drugs for an undisclosed oncology target. The partnership will combine Isomorphic’s AI-driven drug…
    STAT · 1d agoDealPositive↗ source
  • U.S. loses measles elimination status as outbreaks claim first deaths in decades
    The Pan American Health Organization announced that the United States has lost its measles elimination status, a designation it held for 26 years. The decision follows a year‑long period of sustain…
    STAT · 14h agoNegative↗ source
  • Study finds malaria antibody L9LS reduces vaccine response in infants
    Researchers in Mali tested the monoclonal antibody L9LS in infants to see if it could protect against malaria and complement the R21 vaccine. The trial showed L9LS provided about 78% protection ov…
    STAT · 15h agoNegative readoutNegative↗ source
  • Sanofi receives FDA clearance for Infilbray, first pill to treat neurological symptoms of Type 3 Gaucher disease
    Sanofi received FDA clearance for Infilbray, a once-daily pill for Type 3 Gaucher disease in adults and children weighing at least 15 kilograms. The drug, inherited from Sanofi’s 2011 acquisition…
    BioPharma Dive · 20h agoApprovalPositive↗ source
  • Lawmakers push for stronger U.S. biotech support to stay ahead of China
    Members of the congressional Biotech Caucus told reporters that Washington must act quickly to boost the U.S. biotech sector and keep it ahead of China. They called for increased funding, streamli…
    STAT · 20h agoRegulatoryNeutral↗ source
  • Telehealth firms Hims & Hers and Noom launch prescription peptide programs after HHS rule change
    Telehealth companies Hims & Hers and Noom announced this week that they will begin prescribing peptide products to eligible patients, marking the first major consumer‑focused rollouts of such thera…
    STAT · 20h agoNeutral↗ source
  • Grand Strand Sandwich Co. recalls four Lunch Box sandwich products over Listeria risk
    Grand Strand Sandwich Company Inc. announced a recall of four Lunch Box sandwich items because they may be contaminated with Listeria monocytogenes. The recalled products are the Chicken Sausage B…
    fda recalls · 1d agoCRLNegative↗ source
  • Outset Medical issues safety alert for Tablo dialysis system power cords overheat risk
    The FDA’s Center for Devices and Radiological Health has posted an Early Alert after learning that certain power cords used with Outset Medical’s Tablo hemodialysis consoles and the TabloCart with…
    fda medwatch · 1d agoRegulatoryNeutral↗ source
  • Drugmakers urged to assess device capabilities and engage regulators early for combo products
    At the AFDO/RAPS Combination Products Summit, a panel of experts advised drugmakers that developing standalone medical devices to be used with their drugs requires careful evaluation of the devices…
    raps · 1d agoRegulatoryNeutral↗ source
  • National Academies urges faster retractions and corrections to protect scientific record
    The National Academies of Sciences, Engineering, and Medicine released a report urging the scientific community to act more quickly when errors or data manipulation are identified in published rese…
    STAT · 21h agoPositive↗ source
  • MAHA PAC spent more on its own D.C. steakhouse events than on a key ally’s House race before midterm losses
    The political arm of Make America Healthy Again (MAHA) directed millions of dollars to its own operations, including a high‑profile dinner in Washington, D.C., rather than funneling that money to c…
    STAT · 1d agoNegative↗ source
  • Early Alert: B. Braun Medical Inc. Updates Use Instructions for Caresite Micro Luer Access Device
    BBMI corrects Caresite devices due to issue with internal piston remaining depressed following disconnection, preventing the valve from fully closing.
    fda medwatch · 1d agoRegulatoryNeutral↗ source
  • UK MHRA launches AdvanceGxP to help drugmakers address good practice early
    The Medicines and Healthcare products Regulatory Agency in the United Kingdom has introduced a new service called AdvanceGxP. The initiative is designed to give pharmaceutical companies early guida…
    raps · 1d agoRegulatoryNeutral↗ source
  • FDA issues final guidance on 510(k) ownership transfers, shortening sections and adding Q&A
    The U.S. Food and Drug Administration has released a final guidance that spells out the duties of owners of 510(k) clearances when a product is sold or transferred to another company. The new docu…
    raps · 1d agoRegulatoryNeutral↗ source